Omni Healthcare is suing the wholesale drug distributor McKesson on behalf of the federal government and 30 states for allegedly repackaging cancer drugs from single-use vials, leading to fraudulent payments and serious infections.
In a rational political environment, there's a strong argument for tax reform—the next item on President Donald Trump's agenda. But we don't live in such an environment. Cutting taxes when the economy is near full employment will do nothing more than blow a massive hole in the federal budget.
As part of the all-cash, $185 million deal, Allscripts will bring in McKesson's Sunrise EHR, which is directed at small hospitals.
The Cherokee Nation claims the companies should have prevented rather than profited from the opioid epidemic and the mass distribution of addictive pain pills.
Drug distributors have come under fire as federal and state officials use the court system to fight the opioid crisis, and now county officials in West Virginia are following suit.
Drug distributor McKesson's technology business has officially merged with Change Healthcare, a revenue cycle and analytics firm.
McKesson Corp. has agreed to pay a record $150 million civil penalty and suspend sales of controlled substances from distribution centers in four states over allegations that it has once again failed to detect and report suspicious orders of controlled substances.
The U.S. Justice Department has completed its review of a proposed merger that would combine San Francisco-based drug distributor McKesson Corp.'s tech business with Nashville-based tech firm Change Healthcare.
A Texas pediatrician says he plans to open a second office with the money he won in an arbitration case against a marketer of electronic health record systems.
The U.S. is in the midst of a major push to pay for healthcare on the basis of quality over quantity, and bundled payments are regarded as an especially promising model. Medicare's Comprehensive Care for Joint Replacement model, which began in April and is mandatory for 800 hospitals in 67...
McKesson Corp. is developing an interoperability platform that leverages fast healthcare interoperability resources in an effort to move providers toward value-based payment models.
Three months after leaving Accretive Health, an embattled revenue-cycle company, Dr. Emad Rizk is now the CEO of Verscend Technologies.